100 episodes

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.

The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.

The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.

The definition of “Innovation” is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare & the PPN is the Pharmacist's biggest fan. 

Pharmacy Podcast Network Todd S. Eury

    • Business News

In March of 2009, Todd S. Eury, launched the Pharmacy Podcast Show. Over the years, the Pharmacy Podcast has accumulated over 75,000+ listeners and subscribers and is the most popular and downloaded podcast about the Pharmacy Industry.

The Pharmacy Podcast Show transformed into the Pharmacy Podcast Network (PPN) in 2014 and will continue to collect the thought leading interviews with some of the most brilliant minds in Pharmacy with over 30 co-hosts. The PPN is a Digital Health Publication and Content Developing partner to the Pharmaceutical industry focusing on Specialty medications, pharmacy business supportive technologies, and industry trends.

The PPN is the world's largest network of podcasts dedicated to the pharmacy professional and industry insiders leading with our hosts interviewing dynamic people in the pharmacy industry making a difference for our profession, customers, and patients.

The definition of “Innovation” is: A new method, idea, product, or process. Processing, implementing, operating, or designing beyond the status-quo. Pharmacists are the HUB of Healthcare & the PPN is the Pharmacist's biggest fan. 

    The V3 Medical Affairs Podcast with Guest Dr. Darshan Kulkarni - PPN Episode 943

    The V3 Medical Affairs Podcast with Guest Dr. Darshan Kulkarni - PPN Episode 943

    Host Dr. Anne Arvizu and Guest Dr. Darshan Kulkarni

    SHOW POST:

    Hey Medical Affairs Friends: Here's a blow-your-mind scenario. At least for people in Medical Affairs functions like Medical Science Liaisons and Medical Information professionals.

    Fact: It's OK for sales reps to discuss, or even 'promote' in some cases the off-label use of a product being marketed by a pharmaceutical company.

    It’s apparently not a question. Now before you get upset or disagree, read on and then listen to our discussion on the #V3Podcast. I had no idea that this was even ‘a thing’. However, this is a real interpretation and FDA standpoint that I learned about when speaking with friend, colleague and fellow USP Grad (Philadelphia College of Pharmacy & Science @USciences), Darshan Kulkarni. He's not your average pharmacist – he’s kind-of way above average in terms of specificity of his background, degrees and experience; and like me, he's a senior consultant to our industry, but from a very complimentary vantage point.

    Specifically, Darshan is the Principal Attorney of the Kulkarni Law Firm and focuses his practice on helping FDA regulated companies successfully promote their products.  He has spent over 20 years advising clients on FDA compliant marketing and has worked as a pharmacist for over a decade. Darshan has experience serving on medical legal regulatory (MLR) boards, in addition to helping companies navigate a variety of privacy-related issues, including HIPAA, GDPR, US state privacy laws and medium-specific laws like the TCPA.  He has also written several book chapters on pharmaceutical marketing for publications including Pharmaceutical and Medical Device Law: Regulation of Research, Development, and Marketing.

    Darshan shares some pivotal cases that have led to much discussion.  So even though Darshan is a PHARMACIST, I give you the warning…he’s also a LAWYER!; (You’ll hear it!) He loves to flip the script, and that’s what makes for a lively, thought provoking, and interesting discussion on a tough topic. It really does take two sides to flesh out this discussion. The verdict for companies after we’ve solved the bio-pharma’s world’s problems? Proceed with caution.

    Even though we have two voices here about this topic, there is always so much to still learn.

    There is also a lot of room for YOUR voice and opinion on the subject, so if you are an industry professional, have a listen and then comment to us on twitter, linked in or other social media or right below this post.

    You can also send comments or questions to support@rxercommunications.com. You’ll be able to download a copy of this transcript on our website, so check back for when it’s ready.

    In conclusion, I believe many people in our industry, especially on the medical affairs side are unaware of the depth and legal background behind this nuanced issue – that FDA DOES ALLOW sales reps to discuss what we thought was previously taboo to discuss. So, for your reading pleasure, we are including multiple links and articles that go beyond the typical FDA guidance document, that you and your teams may find helpful to read, review and discuss here.
    Central Hudson Gas & Electric v Public Service Commission
    IMS v Sorrell
    MIWG Citizens Petition I (Attached)
    US v Caronia (District Court)
    US v Caronia (Appellate)
    MIWG Citizens Petition II
    FDA Distributing Scientific Publications on Unapproved New Uses Guidance
    Amarin District Court
    Pacira
    Amarin Settlement Agreement
    FDA Announced Public Hearing
    PhRMA Amicus Brief in US v Facteau
    https://www.healthaffairs.org/do/10.1377/hblog20140619.039649/full/

    GUEST BIO:

    Dr. Darshan Kulkarni is the Principal Attorney of the Kulkarni Law Firm and focuses his practice on helping FDA regulated companies successfully bring their products to market. He has over 20 years of experience in providing legal, medical, and r

    • 1 hr 3 min
    Digging into a Bottle of Lies; Interview with Katherine Eban - PPN Episode 942

    Digging into a Bottle of Lies; Interview with Katherine Eban - PPN Episode 942

    Bottle of Lies

    • 27 min
    Summer Pharmacy Internships: CVS Health Careers Podcast Series - PPN Episode 941

    Summer Pharmacy Internships: CVS Health Careers Podcast Series - PPN Episode 941

    Today on the CVS Health Careers Pharmacy Podcast Tyson Cromeens, PharmD talks with Jimmy Gallagher RPh about the Summer Pharmacy Internships within CVS Health. We then go directly to the people that have experienced our Pharmacy Internships, current Interns Rachel and Danielle.  Listen and hear about their experiences within CVS Health Summer Internships and learn about just a few of the focused Summer Internship opportunities CVS Health can provide.

    If you are a Pharmacy Intern then this is a must listen for you.
    For more information about CVS Health Careers, click the links below: 
    For Pharmacists: https://jobs.cvshealth.com/pharmacist-overview
    For Internships: https://jobs.cvshealth.com/internships

    • 19 min
    Pharmacists: Your Career, Our Profession, and Taking Action NOW - PPN Episode 940

    Pharmacists: Your Career, Our Profession, and Taking Action NOW - PPN Episode 940

    Dear Pharmacists:

    Who’s driving this "so called" innovation in Pharmacy? We talk about advanced  technology, more efficient healthcare delivery, transparent payment models, and better wellness results.

    Our U.S. based healthcare landscape is at an inflection point. 

    PBM Reform is coming & will combine with other trends to accelerate change in the next 2 to 3 years.

    Two overarching issues are on the minds of healthcare providers: the evolving reimbursement landscape and changes in the healthcare delivery model.

    The thought leaders in healthcare will help dismantle the status-quo separated methods of patient care and build a solid future of collaborative medicine.

    Pharmacist's must be part of this change and take action NOW!! 

    Contact Ken Sternfeld - the Concierge Pharmacist

    ken@rxvipconcierge.com 

    From: by Brian Burgess 

    A new Florida study, released last week, found that major health care companies using pharmacy benefit managers (PBM’s) have positioned themselves to pocket millions of dollars from the state’s Medicaid system that were intended to lower costs for millions of low-income Floridians. The study found that despite processing less than half of one percent of all pharmacy claims, specialty pharmacies affiliated with PBM’s managed to collect 28 percent of the available profit margin from dispensing prescription drugs.

    The study was commissioned by the Florida Pharmacy Association and American Pharmacy Cooperative Inc. using data obtained from Florida’s Agency for Health Care Administration (AHCA) by the Small Business Pharmacies Aligned for Reform.  Smaller pharmacy operators say the report proves that larger, vertically integrated companies that use PBM’s are using “predatory” business practices that short-circuit the free market.

    State lawmakers expressed alarm at the news and underscored the need for greater transparency and oversight when it comes to PBMs’ role in Florida, particularly regarding situations where PBM’s and managed care companies own the pharmacies where they direct patients.

    “Markets fail when markets get corrupted and that is what has happened here. When the middleman is allowed to own the end-retailer then the middlemen’s incentive to manage cost appropriately for the benefit of the chain is broken,” said State Representative Randy Fine at a press conference to discuss the study.

    https://thecapitolist.com/study-finds-millions-in-medicaid-unfairly-pocketed-by-pharmacy-benefit-managers/ 

    • 42 min
    FLORIDA DRUG PRICING REFORM 2020 - PPN Episode 939

    FLORIDA DRUG PRICING REFORM 2020 - PPN Episode 939

    FOR IMMEDIATE RELEASE

    (February 13, 2020 at 1:00p.m.)

    LOCAL PHARMACY HOSTS NEWS CONFERENCE WITH PATIENTS TO DEMAND FLORIDA DRUG PRICING REFORM

    PBM Reform Podcast Series: 

    https://omny.fm/shows/pharmacy-podcast-network/playlists/pbmreform 

    OKEECHOBEE,FLORIDA (02/13/2020) –Okeechobee Discount Drugs is hosting a press conference to call attention to the IMMEDIATE need for drug pricing reform in Florida, citing information from a new report recently released by 3 Axis Advisors, a data consultancy firm specializing in Medicaid claims analysis. The report, entitled “Sunshine in the Black Box of Pharmacy Benefits Management” is a comprehensive Florida Medicaid claims analysis that examined five years’ worth of Medicaid pharmacy data claims - more than 350 million deidentified claims obtained through the state’s “Sunshine Law”.

    “We can no longer stand by and watch our patients and our state continue to be price gouged and played by these giant corporations whose first allegiance is to their shareholders,” said Steven Nelson, RPH and owner at Okeechobee Discount Drugs. “We - healthcare providers and our patients - have to take action if no one else will. We have to stand up and say we’re unwilling to watch our state healthcare system continue to be gamed by corporate analysts whose sole job is looking for loopholes to exploit. The fight is now personal.”

    The Florida Medicaid claims analysis report uncovered several findings including differential drug pricing for the same medication at pharmacies that are very often within walking distance of each other; pricing certain medications very high relative to the acquisition costs, creating incentives for certain pharmacies to over-dispense the drugs; systematic patient steering to managed care organization (MCO) and pharmacy benefit manager (PBM)-owned or affiliated pharmacies, especially for higher-cost “specialty” medications typically prescribed for chronic diseases including cancer;  and a system that ensures MCO- and PBM-owned/affiliated pharmacies receive the benefit of Florida’s $12 billion annual Medicaid spend.

    "As a patient, my biggest concern every month is being able to afford my medications. As a Florida resident and taxpayer I’m upset that a publicly held corporation would think it could just come to our state and take advantage of us like that. We’re not accountants, we’re just everyday people who rely on the system to help us, not to exploit us,” said Brenda Fortner, a longtime resident of Okeechobee.

    “We need to do more than just give lip service to the pricing and access issues that are currently running rampant here in Florida,” said Steven Nelson, RPH at Okeechobee Discount Drugs. “Too many patients and small business pharmacies have been harmed already. Legislators need to take swift action now.”

    CONTACT: Stacey Nelson

    Email: Stacey @ okeedrug.com

    Phone Number: 561.632.6033

    • 9 min
    Proper Drug Disposal : Pennsylvania's Attorney General's Offices Alan McGill - PPN Episode 938

    Proper Drug Disposal : Pennsylvania's Attorney General's Offices Alan McGill - PPN Episode 938

    Special Guest: 

    Alan McGill - Senior Supervisory Special Agent

    Pennsylvania Attorney General's Office 

    How to Safely Dispose of Unused or Expired Medicine
    The best way to dispose of most types* of old, unused, unwanted, or expired medicines (both prescription and over the counter) is to drop off the medicine at a drug take back site, location, or program immediately.

    The Rx Destroyer is a great alternative solution to avoid polluting water supplies and public disposal of personal medication.  End users can find this product at any Walgreens nationwide. Intermittently add your unwanted medication and dispose in common trash when the bottle is filled.

    *Check out the Medication Disposal Q&A for more information including how to dispose of needles and syringes.

    GET More Information here:

    http://rxdestroyer.com/pharmacypodcastnetwork

    • 29 min

Listeners Also Subscribed To